Results 341 to 350 of about 519,424 (350)

Appraising iniparib, the PARP inhibitor that never was—what must we learn?

Nature Reviews Clinical Oncology, 2013
Joaquin Mateo, Michael Ong, David S P Tan   +2 more
exaly  

Acquired resistance to TKIs in solid tumours: learning from lung cancer

Nature Reviews Clinical Oncology, 2014
William Pao, Lecia V Sequist
exaly  

Tyrosine kinase inhibitor special issue

Veterinary and Comparative Oncology, 2012
openaire   +2 more sources

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Vivek Subbiah, Bettina Ryll, Razelle Kurzrock   +2 more
exaly  

Protein tyrosine phosphatases: from genes, to function, to disease

Nature Reviews Molecular Cell Biology, 2006
exaly  

SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Protein-tyrosine-kinase-inhibitors

Reactions Weekly, 2019
openaire   +2 more sources

Neoadjuvant Tyrosine Kinase Inhibitors

Thoracic Surgery Clinics
Gavitt A. Woodard, Ryan J. Kramer, Collin M. Blakely   +2 more
openaire   +1 more source

Protein tyrosine kinase inhibitors

Reactions Weekly, 2018
openaire   +1 more source

Protein-Tyrosine Kinase Inhibitors

2016
openaire   +1 more source